Investor Relations
Tools

Investor Relations

Overview


The Cooper Companies, Inc. ("Cooper") is a global medical device company publicly traded on the NYSE Euronext (NYSE:COO). Cooper is dedicated to being A Quality of Life Company™ with a focus on delivering shareholder value. Cooper operates through two business units, CooperVision and CooperSurgical. CooperVision brings a refreshing perspective on vision care with a commitment to crafting a wide range of high-quality products for contact lens wearers and providing focused practitioner support. CooperSurgical focuses on supplying women's health clinicians with market leading products and treatment options to improve the delivery of healthcare to women. Headquartered in Pleasanton, CA, Cooper has approximately 8,000 employees with products sold in over 100 countries. For more information, please visit www.coopercos.com.

View all »   RSSRecent Press Releases

Jul 10, 2014
The Cooper Companies Declares Cash Dividend

Jun 30, 2014
The Cooper Companies Announces Definitive Agreements to Acquire Sauflon Pharmaceuticals Ltd




2012 Analyst Meeting Company Fact Sheet